Understanding DLX2-DT: A Potential Drug Target for Neurological Disorders

Target Name: DLX2-DT

NCBI ID: G104326193

DLX2-DT

Other Name(s): DLX2-AS1 | TCONS_00003049 | DLX2 divergent transcript

Understanding DLX2-DT: A Potential Drug Target for Neurological Disorders

DLX2-DT (DLX2-AS1), a protein found in the brain, has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

DLX2-DT is a transmembrane protein that is expressed in various tissues and organs, including the brain. It is characterized by a unique extracellular domain that is composed of a long coiled region and a short transmembrane domain. The coiled region is responsible for the protein's unique 3D structure and functions as a scaffold, while the transmembrane domain is responsible for the protein's ability to interact with other molecules.

One of the key features of DLX2-DT is its role in the regulation of neural plasticity, which is the ability of the brain to change and adapt over time. Neural plasticity is critical for the development and progression of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

Research has shown that DLX2-DT is involved in the regulation of several key events that are involved in neural plasticity, including the regulation of neurotransmitter release, the modulation of gene expression, and the regulation of cellular signaling pathways. It is also involved in the regulation of synaptic plasticity, which is the ability of neurons to change and adapt over time.

One of the key functions of DLX2-DT is its role in the regulation of neurotransmitter release.Neurotransmitters are molecules that are used by neurons to communicate with each other and with other cells in the brain. These molecules include dopamine, serotonin, and norepinephrine, among others. Research has shown that DLX2-DT is involved in the regulation of neurotransmitter release and that changes in its expression levels can have a significant impact on the levels of neurotransmitters in the brain.

Another function of DLX2-DT is its role in modulating gene expression.Gene expression is the process by which the instructions in a gene's DNA are used to build and function a protein. Research has shown that DLX2-DT is involved in the regulation of gene expression and that changes in its expression levels can have a significant impact on the levels of proteins in the brain.

In addition to its role in neurotransmitter release and gene expression, DLX2-DT is also involved in the regulation of cellular signaling pathways.Cells use signaling pathways to communicate with each other and with other cells in the body. These pathways are critical for the regulation of cellular processes, including cell growth, differentiation, and survival. Research has shown that DLX2-DT is involved in the regulation of cellular signaling pathways and that changes in its expression levels can have a significant impact on the levels of signaling pathways in the brain.

The unique structure and function of DLX2-DT have made it an attractive target for researchers to study and develop new treatments for various neurological and psychiatric disorders. Its role in the regulation of neural plasticity and its involvement in the regulation of neurotransmitter release, gene expression, and cellular signaling pathways make it a promising candidate for development as a drug or biomarker.

In conclusion, DLX2-DT is a protein that is expressed in various tissues and organs and is involved in the regulation of neural plasticity, neurotransmitter release, gene expression, and cellular signaling pathways. Its unique structure and function make it an attractive target for researchers to study and develop new treatments for various neurological and psychiatric disorders. Further research is needed to fully understand its role in these processes and to develop new treatments based on its unique properties.

Protein Name: DLX2 Divergent Transcript

The "DLX2-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DLX2-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets